Is there any follow-up drug for lorlatinib resistance?

The treatment challenges after lorlatinib resistance is an important issue in the current field of lung cancer treatment. Although the occurrence of drug resistance is inevitable, when facing this challenge, the medical community actively seeks new treatment strategies to provide patients with more hope.

One possible approach is to try other targeted drugs. After drug resistance occurs, doctors may conduct molecular biology testing to understand the specific mechanisms leading to drug resistance. Based on this information, other drugs targeting the ALK or ROS1 pathways can be selected to continue inhibiting the growth of cancer cells as much as possible. Some new ALK inhibitors or other related targeted drugs are continuously being evaluated in clinical trials, providing first-line treatment options for drug-resistant patients.

In addition, combination therapy is also a direction that has attracted much attention. By combining drugs with different mechanisms, the complexity of treatment can be increased and the anti-cancer effect can be improved. Possible combination treatment options include ALK inhibitors combined with immunotherapy, chemotherapy or other targeted drugs. This multiplex treatment modality is designed to bypass resistance mechanisms and maximize the inhibition of cancer progression.

For some patients, clinical trials may be a promising option. Research into new drugs and treatment options is ongoing, and participation in clinical trials provides patients with the opportunity to try new treatments. Not only does this help advance scientific research, it also provides patients with the opportunity to potentially improve their conditions.

Lorlatinib has been launched in China and is included in medical insurance. Patients can purchase it domestically, but the price is relatively high, about 10,000 to 20,000 yuan. For specific medical insurance reimbursement prices, please consult the local hospital pharmacy. There are original lorlatinib drugs and cheaper generic drugs abroad. The cheaper ones are the original drug from Turkey, which costs more than 1,000 yuan, and the original drug from Hong Kong, China, which costs about 30,000 yuan. Generic drugs are mainly generic drugs from Laos and Bangladesh. The price is about several thousand yuan, and the ingredients of the original drugs and generic drugs are basically the same.